Trademark: 88805781
Word
OPDUALAG NIVOLUMAB/RELATLIMAB)
Status Date
Monday, October 30, 2023
Filing Date
Friday, February 21, 2020
Published for Opposition
Tuesday, August 3, 2021
Abandoned Date
Monday, October 30, 2023
5 Pharmaceutical preparations for human use for the treatment and prevention of cancer, all of the foregoing comprising monoclonal antibodies
44 Health care services, namely, providing information to physicians, health care professionals and patients on the topic of health issues, health awareness and pharmaceuticals; Providing a website featuring educational information in the field of healthcare and pharmaceutical preparations; all of the foregoing involving monoclonal antibodies
The mark consists of the term "OPDUALAG" with a curved line over it and the term ("NIVOLUMAB/RELATLIMAB") below it.
Color is not claimed as a feature of the mark.
"NIVOLUMAB/RELATLIMAB"
Oct 30, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 30, 2023
Abandonment - No Use Statement Filed
Aug 2, 2023
Teas Change Of Correspondence Received
Aug 2, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 2, 2023
Teas Change Of Owner Address Received
Mar 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2023
Sou Extension 3 Granted
Mar 7, 2023
Sou Extension 3 Filed
Mar 7, 2023
Sou Teas Extension Received
Sep 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 13, 2022
Sou Extension 2 Granted
Sep 13, 2022
Sou Extension 2 Filed
Sep 13, 2022
Sou Teas Extension Received
Mar 9, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 7, 2022
Sou Extension 1 Granted
Mar 7, 2022
Sou Extension 1 Filed
Mar 7, 2022
Sou Teas Extension Received
Sep 28, 2021
Noa E-Mailed - Sou Required From Applicant
Aug 3, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 3, 2021
Published For Opposition
Jul 14, 2021
Notification Of Notice Of Publication E-Mailed
Jun 30, 2021
Law Office Publication Review Completed
Jun 30, 2021
Approved For Pub - Principal Register
Jun 23, 2021
Teas/Email Correspondence Entered
Jun 23, 2021
Correspondence Received In Law Office
Jun 22, 2021
Assigned To Lie
Apr 9, 2021
Notice Of Revival - E-Mailed
Apr 8, 2021
Teas Response To Office Action Received
Apr 8, 2021
Petition To Revive-Granted
Apr 8, 2021
Teas Petition To Revive Received
Sep 22, 2020
Notification Of Non-Final Action E-Mailed
Sep 22, 2020
Non-Final Action E-Mailed
Sep 22, 2020
Non-Final Action Written
Sep 11, 2020
Teas/Email Correspondence Entered
Sep 11, 2020
Correspondence Received In Law Office
Sep 11, 2020
Teas Response To Office Action Received
Mar 16, 2020
Notification Of Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action E-Mailed
Mar 16, 2020
Non-Final Action Written
Mar 16, 2020
Assigned To Examiner
Feb 26, 2020
Notice Of Design Search Code E-Mailed
Feb 25, 2020
New Application Office Supplied Data Entered
Feb 25, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
